Comparison of Quetiapine and Trazodone Treatment for Insomnia in Dually Diagnosed Veterans
Comparison of Quetiapine and Trazodone Treatment for Insomnia in Dually Diagnosed Veterans: an Open (e.g. Unblinded) Randomized Stay-Switch Pilot Trial
Sponsor: VA Connecticut Healthcare System
Terminated
it became clear that recruitment was infeasible
Other terminated trials from VA Connecticut Healthcare System
This PHASE4 trial investigates Insomnia and Mental Health Disorder and is currently terminated or withdrawn. VA Connecticut Healthcare System leads this study, which shows 9 recorded versions since 2012 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE4
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE4
▶ Show 4 earlier versions
-
Nov 2018 — Jan 2021 [monthly]
Terminated PHASE4
Status: Unknown Status → Terminated
-
Jun 2018 — Nov 2018 [monthly]
Unknown Status PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
Status: Enrolling By Invitation → Unknown Status
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation PHASE4
First recorded
Jul 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- VA Connecticut Healthcare System
For direct contact, visit the study record on ClinicalTrials.gov .